Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Terminated 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1High Risk Hematologic Malignancy 1Congenital Abnormalities 1

Interventions

fludarabine phosphate 2Melphalan 2Etoposide 2Cyclophosphamide 2apremilast 1Whole-Body Irradiation 1Whole Genome Sequencing 1Valganciclovir 1Transplantation 1Therapeutics 1Tacrolimus 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Genetic Testing 1Gene Expression Profiling 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Cyclosporine 1Busulfan 1Antiviral Agents 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Congenital Abnormalities × Transplantation × Clear all
NCT02094794 2025-07-18

Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML

City of Hope Medical Center

Phase 2 Active not recruiting
108 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡